Buscar resultados de ensayos clínicos
Microsatellite Instability - 23 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer Condición:
|
Completed |
Nombre del estudio: Molecular Biology of Anal Cancer in HIV-Positive Patients Condición:
Fecha: 2009-08-03 |
Active, not recruiting |
Nombre del estudio: Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164) Condición: Colorectal Carcinoma Fecha: 2015-05-29 Intervenciones: Biological: Pembrolizumab IV infusion Other Names: |
Not yet recruiting |
Nombre del estudio: Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types Condición:
|
Recruiting |
Nombre del estudio: A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037/ ECHO-202) Condición:
|
Recruiting |
Nombre del estudio: Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal Cancer Condición: Colorectal Neoplasms Fecha: 2005-09-20 |
Recruiting |
Nombre del estudio: Implementation of a New Strategy to Identify HNPCC Patients Condición:
Fecha: 2005-08-31 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer Condición: Lynch Syndrome Fecha: 2017-01-23 Intervenciones: Other: next-generation sequencing Use next-generation sequencing to test germline mutation and microsate |
Not yet recruiting |
Nombre del estudio: Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC Condición:
Fecha: 2005-10-04 Intervenciones: Procedure: Radiotherapy 50 Gy |
Recruiting |
Nombre del estudio: Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) Condición: Advanced Cancer Fecha: 2015-12-09 Intervenciones: Biological: pembrolizumab intravenous infusion Other |